Top CDMO in APAC
Life Science Review is delighted to announce the Top CDMO in APAC, a distinguished accolade that celebrates pioneers setting new benchmarks in the industry. These companies have earned unmatched reputations and steadfast loyalty from their customers—our dedicated subscribers—as evidenced by the flood of nominations we received. Following an in-depth review by a distinguished panel featuring top C-level leaders, visionary industry experts and our editorial board, these organizations have been recognized for their exemplary leadership, innovative spirit and transformative impact.
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top CDMO in APAC
AsymBio
AsymBio provides biopharmaceutical CDMO services for antibodies, recombinant proteins, bioconjugates and mRNA programs. Its capabilities cover developability assessment, process development, analytical testing, regulatory support and drug substance and drug product manufacturing from early research through clinical and commercial-scale production for global clients.
BioCina
BioCina supports biopharmaceutical programs from early development through commercial supply with integrated drug substance and sterile fill-finish capabilities. Its services cover cell line, process, formulation and analytical development alongside microbial manufacturing, advanced modalities, technology transfer, cGMP production and regulatory support.
LOTTE BIOLOGICS
LOTTE BIOLOGICS delivers end-to-end CDMO services spanning development, clinical manufacturing and commercial production of biological drug substances. Its capabilities include technology transfer, process verification, analytical testing, quality control and antibody-drug conjugate services, supported by manufacturing infrastructure in Korea and the United States.
Thousand Oaks Biologics
Thousand Oaks Biologics supports biologics development and manufacturing through integrated CDMO and CRDMO capabilities. It works across recombinant proteins, antibodies and ADCs, combining cell line and process development, analytical and formulation services, upstream production, downstream purification and drug substance and drug product manufacturing.
WuXi AppTec
Through its integrated CRDMO platform, WuXi AppTec combines pharmaceutical research, development, testing and manufacturing services across the drug lifecycle. Its connected capabilities support discovery programs through commercial production, giving life sciences companies access to chemistry, biology and testing expertise within one global quality system.
CDMO News
